| Document Date: 2014-03-22 14:31:17
Open Document File Size: 484,53 KBShare Result on Facebook
/ Facility University of Washington School / / MedicalCondition arthralgia / FCCP neutropenia / nausea / chronic inflammatory diseases / vomiting / diarrhea / infection / rash / Anemia / / Organization University of Washington / / Person Ibrutinib (Imbruvica) Imatinib / Cabozantinib (Cometriq) Crizotinib / Sunitinib (Sutent) Tofacitinib / John R. Horn / Tofacitinib (Xeljanz) Vandetanib / Dasatinib (Sprycel) Erlotinib / Axitinib (Inlyta) Bosutinib / Vandetanib (Caprelsa) Vemurafenib / Crizotinib (Xalkori) Dabrafenib / Ruxolitinib (Jakafi) Sorafenib / Metabolic Pathways Axitinib / Regorafenib (Stivarga) Ruxolitinib / Ponatinib (Iclusig) Regorafenib / Philip D. Hansten / Bosutinib (Bosulif) Cabozantinib / Nilotinib (Tasigna) Pazopanib / Pazopanib (Votrient) Ponatinib / / Product phenytoin / itraconazole / Sprycel / dexamethasone / Gleevec / Nexavar / carbamazepine / Tasigna / ketoconazole / Iressa / clarithromycin / erythromycin / Rifampin / Sutent / Tykerb / Tarceva / / Technology pharmacokinetics / / URL www.hanstenandhorn.com / www.PharmacyTimes.com / /
SocialTag |
RX FOCUS More @ www. pharmacy times.com